|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,85,800.00 KRW | -1.80% |
|
-7.79% | -7.10% |
| 09/01 | ABL Bio Inc. announced that it has received KRW 21.7244227 billion in funding from Eli Lilly and Company | CI |
| 27/12 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
| Capitalization | 10,27400Cr 705.91Cr 593.18Cr 540.82Cr 516.44Cr 955.6Cr 64TCr 998.3Cr 6.28TCr 2.5TCr 31TCr 2.65TCr 2.59TCr 1,08900Cr | P/E ratio 2025 * |
-21,859x | P/E ratio 2026 * | -326x |
|---|---|---|---|---|---|
| Enterprise value | 1.01TCr 69.61L 58.49L 53.33L 50.93L 94.23L 63Cr 98.44L 6.19Cr 2.47Cr 30Cr 2.61Cr 2.56Cr 107.35Cr | EV / Sales 2025 |
139x | EV / Sales 2026 * | 132x |
| Free-Float |
69.56% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -1.80% | ||
| 1 week | -7.79% | ||
| Current month | -6.02% | ||
| 1 month | -9.14% | ||
| 3 months | +84.88% | ||
| 6 months | +149.40% | ||
| Current year | -7.10% |
| 1 week | 1,74,100 | 1,97,500 | |
| 1 month | 1,72,200 | 2,57,500 | |
| Current year | 1,72,200 | 2,57,500 | |
| 1 year | 31,300 | 2,57,500 | |
| 3 years | 15,370 | 2,57,500 | |
| 5 years | 15,370 | 2,57,500 | |
| 10 years | 12,250 | 2,57,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sang-Hoon Lee
CEO | Chief Executive Officer | 63 | 16/02/2016 |
Jae-Cheon Lee
DFI | Director of Finance/CFO | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Hoon Lee
BRD | Director/Board Member | 63 | 16/02/2016 |
Jae-Cheon Lee
BRD | Director/Board Member | 56 | - |
Jae-Gyun Shin
BRD | Director/Board Member | 54 | 30/03/2023 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.80% | -7.79% | +370.38% | +776.42% | 705.91Cr | ||
| -1.86% | -3.09% | +12.27% | +99.20% | 5.16TCr | ||
| +0.78% | +7.97% | +74.30% | +13.78% | 4.39TCr | ||
| -1.72% | -3.28% | +84.55% | +643.49% | 3.17TCr | ||
| -0.97% | -0.60% | -5.57% | -24.39% | 2.73TCr | ||
| +3.45% | +13.24% | +93.46% | -35.86% | 2.12TCr | ||
| -2.97% | -5.51% | +38.18% | -30.35% | 1.9TCr | ||
| +0.18% | +3.60% | +146.48% | - | 1.3TCr | ||
| -0.47% | +2.43% | +69.68% | +135.61% | 1.25TCr | ||
| -1.62% | -0.06% | +29.91% | +140.96% | 1.16TCr | ||
| Average | -0.75% | +1.06% | +91.36% | +190.98% | 2.39TCr | |
| Weighted average by Cap. | -0.71% | +0.80% | +62.23% | +145.75% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 8.88TCr 6.1Cr 5.12Cr 4.67Cr 4.46Cr 8.26Cr 552.29Cr 8.62Cr 54Cr 22Cr 266.08Cr 23Cr 22Cr 940.41Cr | 7.67TCr 5.27Cr 4.43Cr 4.04Cr 3.86Cr 7.14Cr 477.38Cr 7.45Cr 47Cr 19Cr 229.99Cr 20Cr 19Cr 812.84Cr |
| Net income | -225Cr -15.46L -12.99L -11.84L -11.31L -20.93L -14Cr -21.86L -1.37Cr -54.78L -6.75Cr -57.99L -56.79L -24Cr | -2.25TCr -1.55Cr -1.3Cr -1.18Cr -1.13Cr -2.09Cr -140Cr -2.19Cr -14Cr -5.48Cr -67Cr -5.8Cr -5.68Cr -238.39Cr |
| Net Debt | -14TCr -9.79Cr -8.23Cr -7.5Cr -7.17Cr -13Cr -886.99Cr -14Cr -87Cr -35Cr -427.33Cr -37Cr -36Cr -1.51TCr | -16TCr -11Cr -9.22Cr -8.41Cr -8.03Cr -15Cr -993.71Cr -16Cr -98Cr -39Cr -478.75Cr -41Cr -40Cr -1.69TCr |
Employees
102
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | 1,87,000.00 ₩ | +0.65% | 6,55,244 |
| 10/26/10 | 1,85,800.00 ₩ | -1.80% | 4,22,484 |
| 09/26/09 | 1,89,200.00 ₩ | +6.53% | 9,08,714 |
| 06/26/06 | 1,77,600.00 ₩ | -4.57% | 8,03,326 |
| 05/26/05 | 1,86,100.00 ₩ | -3.37% | 7,53,929 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
5
Last Close Price
1,85,800.00KRW
Average target price
1,83,200.00KRW
Spread / Average Target
-1.40%
Annual profits - Rate of surprise
- Stock Market
- Equities
- A298380 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















